Works matching AU Masato Takahashi


Results: 160
    1

    Radiofrequency Ablation of Breast Cancer: A Retrospective Study.

    Published in:
    2018
    By:
    • Toshikazu Ito;
    • Shoji Oura;
    • Shinji Nagamine;
    • Masato Takahashi;
    • Naohito Yamamoto;
    • Noboru Yamamichi;
    • Mitsuharu Earashi;
    • Hiroyoshi Doihara;
    • Shigeru Imoto;
    • Shoshu Mitsuyama;
    • Kohei Akazawa;
    • Ito, Toshikazu;
    • Oura, Shoji;
    • Nagamine, Shinji;
    • Takahashi, Masato;
    • Yamamoto, Naohito;
    • Yamamichi, Noboru;
    • Earashi, Mitsuharu;
    • Doihara, Hiroyoshi;
    • Imoto, Shigeru
    Publication type:
    journal article
    2
    3
    4
    5

    Associations in tumor infiltrating lymphocytes between clinicopathological factors and clinical outcomes in estrogen receptor-positive/human epidermal growth factor receptor type 2 negative breast cancer.

    Published in:
    Oncology Letters, 2019, v. 17, n. 2, p. 2177
    By:
    • Miyoshi, Yuichiro;
    • Shien, Tadahiko;
    • Ogiya, Akiko;
    • Ishida, Naoko;
    • Yamazaki, Kieko;
    • Horii, Rie;
    • Horimoto, Yoshiya;
    • Masuda, Norikazu;
    • Yasojima, Hiroyuki;
    • Inao, Touko;
    • Osako, Tomofumi;
    • Takahashi, Masato;
    • Tomioka, Nobumoto;
    • Wanifuchi-Endo, Yumi;
    • Hosoda, Mitsuchika;
    • Doihara, Hiroyoshi;
    • Yamashita, Hiroko
    Publication type:
    Article
    6

    In Memoriam: Dr Tomisaku Kawasaki.

    Published in:
    Journal of the Pediatric Infectious Diseases Society, 2020, v. 9, n. 4, p. 515, doi. 10.1093/jpids/piaa081
    By:
    • Shulman, Stanford T;
    • Takahashi, Masato
    Publication type:
    Article
    7
    8

    Clinical significance of comprehensive genomic profiling tests covered by public insurance in patients with advanced solid cancers in Hokkaido, Japan.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 753, doi. 10.1093/jjco/hyaa277
    By:
    • Kikuchi, Junko;
    • Ohhara, Yoshihito;
    • Takada, Kohichi;
    • Tanabe, Hiroki;
    • Hatanaka, Kazuteru;
    • Amano, Toraji;
    • Hatanaka, Kanako C;
    • Hatanaka, Yutaka;
    • Mitamura, Takashi;
    • Kato, Momoko;
    • Shibata, Yuka;
    • Yabe, Ichiro;
    • Endoh, Akira;
    • Komatsu, Yoshito;
    • Matsuno, Yoshihiro;
    • Sugiyama, Minako;
    • Manabe, Atsushi;
    • Sakurai, Akihiro;
    • Takahashi, Masato;
    • Naruse, Hirohito
    Publication type:
    Article
    9
    10
    11

    A randomized, open-label, Phase III trial of pertuzumab retreatment in HER2-positive locally advanced/metastatic breast cancer patients previously treated with pertuzumab, trastuzumab and chemotherapy: the Japan Breast Cancer Research Group-M05 PRECIOUS study

    Published in:
    Japanese Journal of Clinical Oncology, 2018, v. 48, n. 9, p. 855, doi. 10.1093/jjco/hyy097
    By:
    • Yamamoto, Yutaka;
    • Iwata, Hiroji;
    • Ueno, Takayuki;
    • Taira, Naruto;
    • Kashiwaba, Masahiro;
    • Takahashi, Masato;
    • Tada, Hiroshi;
    • Tsugawa, Koichiro;
    • Toyama, Tatsuya;
    • Niikura, Naoki
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18

    Low nuclear grade but not cell proliferation predictive of pathological complete response to docetaxel in human breast cancers.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2008, v. 134, n. 5, p. 561, doi. 10.1007/s00432-007-0319-5
    By:
    • Miyoshi, Yasuo;
    • Kurosumi, Masafumi;
    • Kurebayashi, Junichi;
    • Matsuura, Nariaki;
    • Takahashi, Masato;
    • Tokunaga, Eriko;
    • Egawa, Chiyomi;
    • Masuda, Norikazu;
    • Kim, Seung;
    • Okishiro, Masatsugu;
    • Yanagisawa, Tetsu;
    • Ueda, Satsuki;
    • Taguchi, Tetsuya;
    • Tamaki, Yasuhiro;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    19
    20
    21
    22

    Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients: extended follow-up of JBCRG-cohort study 01.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 4, p. 631, doi. 10.1007/s12282-020-01057-4
    By:
    • Yamashiro, Hiroyasu;
    • Iwata, Hiroji;
    • Masuda, Norikazu;
    • Yamamoto, Naohito;
    • Nishimura, Reiki;
    • Ohtani, Shoichiro;
    • Sato, Nobuaki;
    • Takahashi, Masato;
    • Kamio, Takako;
    • Yamazaki, Kosuke;
    • Saito, Tsuyoshi;
    • Kato, Makoto;
    • Lee, Tecchuu;
    • Kuroi, Katsumasa;
    • Takano, Toshimi;
    • Yasuno, Shinji;
    • Morita, Satoshi;
    • Ohno, Shinji;
    • Toi, Masakazu;
    • the JBCRG-C01 Collaborative Group
    Publication type:
    Article
    23

    The Japanese Breast Cancer Society Clinical Practice Guidelines for systemic treatment of breast cancer, 2018 edition.

    Published in:
    Breast Cancer (13406868), 2020, v. 27, n. 3, p. 322, doi. 10.1007/s12282-020-01085-0
    By:
    • Shimoi, Tatsunori;
    • Nagai, Shigenori E.;
    • Yoshinami, Tetsuhiro;
    • Takahashi, Masato;
    • Arioka, Hitoshi;
    • Ishihara, Mikiya;
    • Kikawa, Yuichiro;
    • Koizumi, Kei;
    • Kondo, Naoto;
    • Sagara, Yasuaki;
    • Takada, Masahiro;
    • Takano, Toshimi;
    • Tsurutani, Junji;
    • Naito, Yoichi;
    • Nakamura, Rikiya;
    • Hattori, Masaya;
    • Hara, Fimikata;
    • Hayashi, Naoki;
    • Mizuno, Toshiro;
    • Miyashita, Minoru
    Publication type:
    Article
    24

    Bi-weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST-STUDY).

    Published in:
    Breast Cancer (13406868), 2018, v. 25, n. 4, p. 438, doi. 10.1007/s12282-018-0843-y
    By:
    • Ohtani, Shoichiro;
    • Nakayama, Takahiro;
    • Yoshinami, Tetsuhiro;
    • Watanabe, Ken-ichi;
    • Hara, Fumikata;
    • Sagara, Yasuaki;
    • Kawaguchi, Hidetoshi;
    • Higaki, Kenji;
    • Matsunami, Nobuki;
    • Hasegawa, Yoshie;
    • Takahashi, Masato;
    • Mizutani, Makiko;
    • Morimoto, Takashi;
    • Sato, Masako;
    • Itoh, Mitsuya;
    • Morita, Satoshi;
    • Masuda, Norikazu
    Publication type:
    Article
    25
    26
    27

    Post-relapse survival in patients with the early and late distant recurrence in estrogen receptor-positive HER2-negative breast cancer.

    Published in:
    Breast Cancer (13406868), 2017, v. 24, n. 3, p. 473, doi. 10.1007/s12282-016-0730-3
    By:
    • Ogiya, Akiko;
    • Yamazaki, Kieko;
    • Horii, Rie;
    • Shien, Tadahiko;
    • Horimoto, Yoshiya;
    • Masuda, Norikazu;
    • Inao, Touko;
    • Hosoda, Mitsuchika;
    • Ishida, Naoko;
    • Osako, Tomofumi;
    • Takahashi, Masato;
    • Endo, Yumi;
    • Miyoshi, Yuichiro;
    • Yasojima, Hiroyuki;
    • Tomioka, Nobumoto;
    • Yamashita, Hiroko
    Publication type:
    Article
    28

    Clinicopathological factors predicting early and late distant recurrence in estrogen receptor-positive, HER2-negative breast cancer.

    Published in:
    Breast Cancer (13406868), 2016, v. 23, n. 6, p. 830, doi. 10.1007/s12282-015-0649-0
    By:
    • Yamashita, Hiroko;
    • Ogiya, Akiko;
    • Shien, Tadahiko;
    • Horimoto, Yoshiya;
    • Masuda, Norikazu;
    • Inao, Touko;
    • Osako, Tomofumi;
    • Takahashi, Masato;
    • Endo, Yumi;
    • Hosoda, Mitsuchika;
    • Ishida, Naoko;
    • Horii, Rie;
    • Yamazaki, Kieko;
    • Miyoshi, Yuichiro;
    • Yasojima, Hiroyuki;
    • Tomioka, Nobumoto
    Publication type:
    Article
    29
    30

    Prevalence and differentiation of hereditary breast and ovarian cancers in Japan.

    Published in:
    Breast Cancer (13406868), 2015, v. 22, n. 5, p. 462, doi. 10.1007/s12282-013-0503-1
    By:
    • Nakamura, Seigo;
    • Takahashi, Masato;
    • Tozaki, Mitsuhiro;
    • Nakayama, Takahiro;
    • Nomizu, Tadashi;
    • Miki, Yoshio;
    • Murakami, Yoshie;
    • Aoki, Daisuke;
    • Iwase, Takuji;
    • Nishimura, Seiichiro;
    • Yamauchi, Hideko;
    • Ohsumi, Shozo;
    • Baba, Shinichi;
    • Shimizu, Tadao
    Publication type:
    Article
    31
    32
    33

    Predictive factors for anthracycline-based chemotherapy for human breast cancer.

    Published in:
    Breast Cancer (13406868), 2010, v. 17, n. 2, p. 103, doi. 10.1007/s12282-009-0152-6
    By:
    • Miyoshi, Yasuo;
    • Kurosumi, Masafumi;
    • Kurebayashi, Junichi;
    • Matsuura, Nariaki;
    • Takahashi, Masato;
    • Tokunaga, Eriko;
    • Egawa, Chiyomi;
    • Masuda, Norikazu;
    • Kono, Seishi;
    • Morimoto, Koji;
    • Kim, Seung;
    • Okishiro, Masatsugu;
    • Yanagisawa, Tetsu;
    • Ueda, Satsuki;
    • Taguchi, Tetsuya;
    • Tamaki, Yasuhiro;
    • Noguchi, Shinzaburo
    Publication type:
    Article
    34
    35
    36
    37
    38
    39
    40

    Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 10, p. 1654, doi. 10.1093/jnci/djae129
    By:
    • Dent, Rebecca;
    • Cortés, Javier;
    • Pusztai, Lajos;
    • McArthur, Heather;
    • Kümmel, Sherko;
    • Bergh, Jonas;
    • Denkert, Carsten;
    • Park, Yeon Hee;
    • Hui, Rina;
    • Harbeck, Nadia;
    • Takahashi, Masato;
    • Untch, Michael;
    • Fasching, Peter A;
    • Cardoso, Fatima;
    • Haiderali, Amin;
    • Jia, Liyi;
    • Nguyen, Allison Martin;
    • Pan, Wilbur;
    • O'Shaughnessy, Joyce;
    • Schmid, Peter
    Publication type:
    Article
    41
    42

    Cost-Effectiveness of Trastuzumab With or Without Chemotherapy as Adjuvant Therapy in HER2-Positive Elderly Breast Cancer Patients: A Randomized, Open-Label Clinical Trial, the RESPECT Trial.

    Published in:
    Clinical Drug Investigation, 2022, v. 42, n. 3, p. 253, doi. 10.1007/s40261-022-01124-y
    By:
    • Takumoto, Yuki;
    • Shiroiwa, Takeru;
    • Shimozuma, Kojiro;
    • Iwata, Hiroji;
    • Takahashi, Masato;
    • Baba, Shinichi;
    • Kobayashi, Kokoro;
    • Hagiwara, Yasuhiro;
    • Kawahara, Takuya;
    • Uemura, Yukari;
    • Mukai, Hirofumi;
    • Taira, Naruto;
    • Sawaki, Masataka
    Publication type:
    Article
    43

    Correction to: Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).

    Published in:
    2020
    By:
    • Yamashita, Toshinari;
    • Masuda, Norikazu;
    • Saji, Shigehira;
    • Araki, Kazuhiro;
    • Ito, Yoshinori;
    • Takano, Toshimi;
    • Takahashi, Masato;
    • Tsurutani, Junji;
    • Koizumi, Kei;
    • Kitada, Masahiro;
    • Kojima, Yasuyuki;
    • Sagara, Yasuaki;
    • Tada, Hiroshi;
    • Iwasa, Tsutomu;
    • Kadoya, Takayuki;
    • Iwatani, Tsuguo;
    • Hasegawa, Hiroki;
    • Morita, Satoshi;
    • Ohno, Shinji
    Publication type:
    journal article
    44

    Trastuzumab, pertuzumab, and eribulin mesylate versus trastuzumab, pertuzumab, and a taxane as a first-line or second-line treatment for HER2-positive, locally advanced or metastatic breast cancer: study protocol for a randomized controlled, non-inferiority, phase III trial in Japan (JBCRG-M06/EMERALD).

    Published in:
    2020
    By:
    • Yamashita, Toshinari;
    • Masuda, Norikazu;
    • Saji, Shigehira;
    • Araki, Kazuhiro;
    • Ito, Yoshinori;
    • Takano, Toshimi;
    • Takahashi, Masato;
    • Tsurutani, Junji;
    • Koizumi, Kei;
    • Kitada, Masahiro;
    • Kojima, Yasuyuki;
    • Sagara, Yasuaki;
    • Tada, Hiroshi;
    • Iwasa, Tsutomu;
    • Kadoya, Takayuki;
    • Iwatani, Tsuguo;
    • Hasegawa, Hiroki;
    • Morita, Satoshi;
    • Ohno, Shinji
    Publication type:
    journal article
    45

    Assessment for the timing of comprehensive genomic profiling tests in patients with advanced solid cancers.

    Published in:
    Cancer Science, 2023, v. 114, n. 8, p. 3385, doi. 10.1111/cas.15837
    By:
    • Hagio, Kanako;
    • Kikuchi, Junko;
    • Takada, Kohichi;
    • Tanabe, Hiroki;
    • Sugiyama, Minako;
    • Ohhara, Yoshihito;
    • Amano, Toraji;
    • Yuki, Satoshi;
    • Komatsu, Yoshito;
    • Osawa, Takahiro;
    • Hatanaka, Kanako C.;
    • Hatanaka, Yutaka;
    • Mitamura, Takashi;
    • Yabe, Ichiro;
    • Matsuno, Yoshihiro;
    • Manabe, Atsushi;
    • Sakurai, Akihiro;
    • Ishiguro, Atsushi;
    • Takahashi, Masato;
    • Yokouchi, Hiroshi
    Publication type:
    Article
    46

    Pertuzumab retreatment for HER2‐positive advanced breast cancer: A randomized, open‐label phase III study (PRECIOUS).

    Published in:
    Cancer Science, 2022, v. 113, n. 9, p. 3169, doi. 10.1111/cas.15474
    By:
    • Yamamoto, Yutaka;
    • Iwata, Hiroji;
    • Taira, Naruto;
    • Masuda, Norikazu;
    • Takahashi, Masato;
    • Yoshinami, Tetsuhiro;
    • Ueno, Takayuki;
    • Toyama, Tatsuya;
    • Yamanaka, Takashi;
    • Takano, Toshimi;
    • Kashiwaba, Masahiro;
    • Tsugawa, Koichiro;
    • Hasegawa, Yoshie;
    • Tamura, Kenji;
    • Tada, Hiroshi;
    • Hara, Fumikata;
    • Fujisawa, Tomomi;
    • Niikura, Naoki;
    • Saji, Shigehira;
    • Morita, Satoshi
    Publication type:
    Article
    47
    48
    49
    50